PH25109A - Antibiotic solutions and the lyophilization thereof - Google Patents

Antibiotic solutions and the lyophilization thereof

Info

Publication number
PH25109A
PH25109A PH37669A PH37669A PH25109A PH 25109 A PH25109 A PH 25109A PH 37669 A PH37669 A PH 37669A PH 37669 A PH37669 A PH 37669A PH 25109 A PH25109 A PH 25109A
Authority
PH
Philippines
Prior art keywords
gel
lyophilization
concentration
antibiotic solutions
vancomycin hydrochloride
Prior art date
Application number
PH37669A
Other languages
English (en)
Inventor
Robert Lee Robison
Original Assignee
Robert Lee Robison
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22330088&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PH25109(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Robert Lee Robison filed Critical Robert Lee Robison
Publication of PH25109A publication Critical patent/PH25109A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
PH37669A 1987-10-15 1988-10-12 Antibiotic solutions and the lyophilization thereof PH25109A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/109,885 US4885275A (en) 1987-10-15 1987-10-15 Vancomycin-HCL solutions and the lyophilization thereof

Publications (1)

Publication Number Publication Date
PH25109A true PH25109A (en) 1991-02-19

Family

ID=22330088

Family Applications (1)

Application Number Title Priority Date Filing Date
PH37669A PH25109A (en) 1987-10-15 1988-10-12 Antibiotic solutions and the lyophilization thereof

Country Status (17)

Country Link
US (1) US4885275A (ko)
EP (1) EP0318146B1 (ko)
JP (2) JP2883890B2 (ko)
KR (1) KR970007907B1 (ko)
AT (1) ATE74013T1 (ko)
AU (1) AU610936B2 (ko)
CA (1) CA1326211C (ko)
DE (1) DE3869563D1 (ko)
DK (1) DK167141B1 (ko)
ES (1) ES2036690T3 (ko)
GR (1) GR3004155T3 (ko)
HU (1) HU200558B (ko)
IE (1) IE61049B1 (ko)
IL (1) IL88024A (ko)
NZ (1) NZ226550A (ko)
PH (1) PH25109A (ko)
ZA (1) ZA887579B (ko)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03193735A (ja) * 1989-12-22 1991-08-23 Shionogi & Co Ltd グリコペプチド系抗生物質の安定化組成物
WO1997019690A1 (en) * 1995-12-01 1997-06-05 Eli Lilly And Company Stable vancomycin hydrochloride solutions
US5786022A (en) * 1996-10-31 1998-07-28 Ethicon, Inc. Coating mixture for surgical articles
WO1999017793A1 (fr) * 1997-10-03 1999-04-15 Fujisawa Pharmaceutical Co., Ltd. Chlorhydrates de vancomycines antibiotiques et leur procede de production
JP3875023B2 (ja) * 1998-02-13 2007-01-31 コリア リサーチ インスティチュート オブ ケミカル テクノロジイ コアー殻触媒相の固形触媒とその製造方法
UA75083C2 (uk) * 2000-06-22 2006-03-15 Тераванс, Інк. Похідні глікопептидфосфонатів
AU2002224526A1 (en) 2000-07-24 2002-02-05 Ono Pharmaceutical Co. Ltd. Freeze-dried preparation of n-(o-(p-pivaloyloxybenzenesulfonylamino)benzoyl)glycine monosodium salt tetrahydrate and process for producing the same
US20060074014A1 (en) 2002-11-18 2006-04-06 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections
TWI342312B (en) * 2003-10-22 2011-05-21 Theravance Inc Hydrochloride salts of a glycopeptide phosphonate derivative
US8182461B2 (en) 2003-11-04 2012-05-22 Smiths Medical Asd, Inc. Syringe pump rapid occlusion detection system
JP5280813B2 (ja) * 2007-11-28 2013-09-04 日医工株式会社 グリコペプチド類含有凍結乾燥組成物及びその製造方法
KR101101663B1 (ko) * 2009-01-13 2011-12-30 (주) 제노텍 반코마이신 습체의 정제방법
US9616098B2 (en) 2013-05-30 2017-04-11 Scidose, Llc Formulations of vancomycin
EP3906917A1 (en) 2016-01-15 2021-11-10 SciDose Pharma LLC Formulations of vancomycin
US10729708B2 (en) 2016-05-09 2020-08-04 Xellia Pharmaceuticals Aps Stabilized glycopeptide antibiotic formulations
US11433115B2 (en) 2020-10-30 2022-09-06 Somerset Therapeutics, Llc Glycopeptide antibiotics liquid formulations and methods and uses thereof
CN112691083B (zh) * 2020-12-28 2022-05-06 瀚晖制药有限公司 盐酸万古霉素的冻干工艺
WO2024092091A1 (en) * 2022-10-26 2024-05-02 Thomas Jefferson University Biodegradable pocket for drug delivery and associated methods

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3067099A (en) * 1955-09-16 1962-12-04 Lilly Co Eli Vancomycin and method for its preparation
HU176215B (en) * 1978-01-27 1981-01-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing a cyclodextrin-indomethacin inclusion complex with a ratio of at about 2:1
US4378348A (en) * 1979-12-28 1983-03-29 Otsuka Pharmaceutical Co., Ltd. OA-7653 Substance
JPS58177949A (ja) * 1982-04-12 1983-10-18 Takeda Chem Ind Ltd ランカシジン群抗生物質包接化合物
US4670258A (en) * 1984-02-10 1987-06-02 Vanderbilt University Storable prepackaged aqueous solutions of vancomycin
US4547488A (en) * 1984-04-16 1985-10-15 Eli Lilly And Company Antibiotic M43D, pharmaceutical compositions and method of use
AU618517B2 (en) * 1986-12-23 1992-01-02 Eugene J. Van Scott Additives enhancing topical actions of therapeutic agents

Also Published As

Publication number Publication date
DK570588A (da) 1989-04-16
DE3869563D1 (de) 1992-04-30
ES2036690T3 (es) 1993-06-01
EP0318146A1 (en) 1989-05-31
JPH1081619A (ja) 1998-03-31
NZ226550A (en) 1990-04-26
DK570588D0 (da) 1988-10-13
GR3004155T3 (ko) 1993-03-31
DK167141B1 (da) 1993-09-06
KR890006243A (ko) 1989-06-12
IE883129L (en) 1989-04-15
ZA887579B (en) 1990-06-27
CA1326211C (en) 1994-01-18
ATE74013T1 (de) 1992-04-15
HUT49285A (en) 1989-09-28
IE61049B1 (en) 1994-09-21
JP2983934B2 (ja) 1999-11-29
IL88024A (en) 1993-04-04
EP0318146B1 (en) 1992-03-25
AU2369688A (en) 1989-06-08
HU200558B (en) 1990-07-28
IL88024A0 (en) 1989-06-30
JP2883890B2 (ja) 1999-04-19
AU610936B2 (en) 1991-05-30
KR970007907B1 (ko) 1997-05-17
US4885275A (en) 1989-12-05
JPH01146825A (ja) 1989-06-08

Similar Documents

Publication Publication Date Title
PH25109A (en) Antibiotic solutions and the lyophilization thereof
HUT44415A (en) Fungicides comprising alpha-aryl-alpha-phenyl-ethyl-1h 1,2,4 triazole-1-propanenitrile derivatives as active substance and process for preparing the active substance
AU610636B2 (en) Stabilised human protein preparations
IL76138A (en) Pharmaceutical formulation in the form of sucralfate suspension and its preparation
IL84446A0 (en) 3-pyrrolidinylthio-1-azabicyclo-(3.2.0)hept-2-ene-2-carboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
FI885398A0 (fi) Menetelmä stabiilin, puristetussa muodossa olevan farmaseuttisen koostumuksen valmistamiseksi
HUT44414A (en) Pesticide comprising 1,2,3,6 tetrahydro-5-nitropyrimidine derivatives as active substance and process for preparing the active substance
GR890300196T1 (en) Pharmaceutical compositions of piroxicam in aqueous solutions and process for their preparation
HUT43828A (en) Process for producing 1,1-disubstituted cyclopropan derivatives and pharmaceutical and/or fungicide compositions containing them as active agents
HUT44908A (en) Fungicides comprising triazolyl- or imidazolyl-group-substituted 2,5-dihydrofuran derivatives as active ingredient and process for producing the active ingredient and intermediaries thereof
HUT49450A (en) Insecticides and acaricides containing as active substance derivatives of 2,2 difluor cycloprophil ethan and process for production of the active substance
HUT44412A (en) Fungicides comprising trisubstituted 1,3,5-triazine-2,4,6-trione derivatives as active substance and process for preparing the active substances
ZA934037B (en) Novel biologically active eburnamenine derivatives, pharmaceutical compositions containing them and process for preparing same.
TW290455B (ko)
HU906967D0 (en) Fungicide preparatives containing new amino acid amine derivatives as active substance and process for producing the active substances
HUT43829A (en) Process for producing 1,1-disubstituted cyclopropan derivatives and pharmaceutical and/or fungicide compositions containing them as active agents
HUT41230A (en) Pesticide compositions containing substituted 4,5-dihydro-1,3,4-thiadiazol derivatives as active agents and process for producing the active agents
AU6724581A (en) Plenylpiperazine derivatives of 1,3,4-oxiadiazolylphends
HUT42761A (en) Fungicidal composition comprising phenyl-sulfonyl-azole derivatives as active substance and process for preparing the active substance
HUT43315A (en) Herbicidal composition comprising 2-aryl-4,5,6,7-tetrahydro-isoindoline derivatives as active substance and process for preparing the active substance
HUT46838A (en) Pesticide compositions containing 2,5-bis-pyridyl-1,3,4-thiadiazol derivatives as active components and process for producing the active components
GR3021646T3 (en) Protein curuculin and application of the same
HUT43049A (en) Fungicides comprising 1,4-disubstituted 1-azolyl-3,3-dimethyl-butan-2-one and -ol derivatives as active substance and process for preparing the active substances
IL99389A0 (en) Amino acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
DE68916275D1 (de) 1-Carbacephalosporin-Antibiotika.